International Journal of Travel Medicine and Global Health

International Journal of Travel Medicine and Global Health

A case of borderline leprosy revealed by immunosuppressive treatment for systemic lupus erythematous

Document Type : Case Report

Authors
1 Migrant Health Unit, Primary Care Department of Piacenza
2 Migration Health Unit, Primary Health Care Department, Piacenza, Italy
3 Infectious Diseases Unit, “G. da Saliceto” Hospital of Piacenza, Italy
4 Pathology Unit, “G. da Saliceto” Hospital of Piacenza, Italy
Abstract
Leprosy is an endemic mycobacterial infection caused by acid-fast bacilli (M. leprae) mainly involving the skin and the peripheral nerves 1, 2. The means of transmission is not fully understood 3; individuals with sufficient exposure and susceptibility to M. leprae complex may develop a broad range of clinical manifestations, which vary depending upon the host's ability to mount an acquired immune response to infection 3, 4. The spectra of immunological mechanisms can mimick connective tissue disorders 5.
Here we report a case of 31-year-old man, traveling from Ghana to Italy in 2016; the initial clinical findings (bullous erysipelas of the hands and hypotrophy of the hypotenar region with the flexion of the fourth and fifth proximal interphalangeal joints) suggested possible leprosy, but the skin biopsies were negative for mycobacteria. Over the following six years, the biochemical and hystopathological data together with the symptoms developed by the patient, have been evaluated separately by the various specialists (dermatologists, rheumatologists and nephrologists), with final diagnosis of lupus. Therefore, clinicians started immunosuppressive treatment, without improvement.
The absence of acid-fast bacilli in the skin biopsies and the lack of neurological manifestations delayed the diagnosis until the general conditions worsened (increase of proteinuria, generalized oedema, recurrence of skin ulcers, appearance of annular lesions); the patient was transferred to Referral Hospital to be tested for polymerase chain reaction (PCR).
The clinical, serological and histological similarities between leprosy and autoimmune diseases may lead to erroneous and delayed diagnosis, with potential clinical and emotional sequelae requiring long-life care.
Keywords

Volume 12, Issue 3
Summer 2024
Pages 189-193

  • Receive Date 02 January 2024
  • Revise Date 30 January 2024
  • Accept Date 02 February 2024